Fecal calprotectin levels in patients with colonic polyposis

Digestive Diseases and Sciences

Volumn 53, Issue 1, 2008, Pages 47-51

  Pezzilli, Raffaele ^a   Barassi, Alessandra ^b   Morselli Labate, Antonio M ^a   Finazzi, Sergio ^c   Fantini, Lorenzo ^a   Gizzi, Giuseppe ^a   Lotzniker, Milvia ^c   Villani, Valeria ^a   Melzi D'Eril, Gianvico ^b   Corinaldesi, Roberto ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c Legnano Hospital   (Italy)

Author keywords

Calcium binding proteins; Colon; Colonic polyps; Colonoscopy; Diverticulum; Leukocyte L1 Antigen Complex

Indexed keywords

CALGRANULIN;

ADULT; AGED; ARTICLE; COLON POLYPOSIS; CONTROLLED STUDY; DIVERTICULOSIS; FECES ANALYSIS; FEMALE; GASTROINTESTINAL ENDOSCOPY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADULT; AGED; BIOLOGICAL MARKERS; COLONIC POLYPS; COLONOSCOPY; DIAGNOSIS, DIFFERENTIAL; DIVERTICULUM, COLON; ENZYME-LINKED IMMUNOSORBENT ASSAY; FECES; FEMALE; HUMANS; LEUKOCYTE L1 ANTIGEN COMPLEX; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 37249093997     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-007-9820-6     Document Type: Article

References (24)

1. Johns LE, Houlston RS (2001) A systematic review and meta-analysis of familial colorectal cancer risk. Am J Gastroenterol 96:2992-3003
2. Jorgensen OD, Kronborg O, Fenger C (1993) The funen adenoma follow-up study. Incidence and death from colorectal carcinoma in an adenoma surveillance program. Scan J Gastroenterol 28:869-874
3. Rex DK, Johnson DA, Lieberman DA (2000) Colorectal cancer prevention: screening recommendations of the American College of Gastroenterology. Am J Gastroenterol 95:868-877
4. O'Hare A, Fenlon H (2006) Virtual colonoscopy in the detection of colonic polyps and neoplasms. Best Pract Res Clin Gastroenterol 20:79-92
5. Ahmed FE (2003) Colon cancer: prevalence, screening, gene expression and mutation, and risk factors and assessment. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev 21:65-131
6. Gutfeld O, Prus D, Ackerman Z, Dishon S, Linke RP, Levin M, Urieli-Shoval S (2006) Expression of serum amyloid A, in normal, dysplastic, and neoplastic human colonic mucosa: implication for a role in colonic tumorigenesis. J Histochem Cytochem 54:63-73
7. Voganatsi A, Panyutich A, Miyasaki KT, Murthy RK (2001) Mechanism of extracellular release of human neutrophil calprotectin complex. J Leukoc Biol 70:130-134
8. Roseth AG, Fagerhol MK, Aadland E, Schjonsby H (1992) Assessment of the neutrophil dominating protein calprotectin in feces. A methodologic study. Scand J Gastroenterol 27:793-798
9. D'Inca R, Dal Pont E, Di Leo V, Ferronato A, Fries W, Vettorato MG, Martines D, Sturniolo GC (2006) Calprotectin and lactoferrin in the assessment of intestinal inflammation and organic disease. Int J Colorectal Dis epub ahead of print
10. Orlando A, Modesto I, Castiglione F, Scala L, Scimeca D, Rispo A, Teresi S, Mocciaro F, Criscuoli V, Marrone C, Platania P, De Falco T, Maisano S, Nicoli N, Cottone M (2006) The role of calprotectin in predicting endoscopic post-surgical recurrence in asymptomatic Crohn's disease: a comparison with ultrasound. Eur Rev Med Pharmacol Sci 10:17-22
11. Vermeire S, Van Assche G, Rutgeerts P (2006) Laboratory markers in IBD: useful, magic, or unnecessary toys? Gut 55:426-431
12. Bremner A, Roked S, Robinson R, Phillips I, Beattie M (2005) Faecal calprotectin in children with chronic gastrointestinal symptoms. Acta Paediatr 94:1855-1858
13. Vieten D, Cairns P (2005) The role of calprotectin in the diagnosis of neonatal necrotising enterocolitis. Ir Med J 98:69
14. Roseth AG (2003) Determination of faecal calprotectin, a novel marker of organic gastrointestinal disorders. Dig Liver Dis 35:607-609
15. Tibble JA, Sigthorsson G, Foster R, Scott D, Fagerhol MK, Roseth A, Bjarnason I (1999) High prevalence of NSAID enteropathy as shown by a simple faecal test. Gut 45:362-6
16. Homann C, Christensen E, Schlichting P, Philipsen EK, Graudal NA, Garred P (2003) Ascites fluid and plasma calprotectin concentrations in liver disease. Scand J Gastroenterol 38:415-420
17. Ton H, Brandsnes, Dale S, Holtlund J, Skuibina E, Schjonsby H, Johne B (2000) Improved assay for fecal calprotectin. Clin Chim Acta 292:41-54
18. Saverymuttu SH, Maltby P, Batman P, Joseph AE, Maxwell D (1986) False positive localisation of indium-111 granulocytes in colonic carcinoma. Br J Radiol 59:773-777
19. Tibble J, Sigthorsson G, Foster R, Sherwood R, Fagerhol M, Bjarnason I (2001) Faecal calprotectin and faecal occult blood tests in the diagnosis of colorectal carcinoma and adenoma. Gut 49:402-408
20. Hoff G, Grotmol T, Thiis-Evensen E, Bretthauer M, Gondal G, Vatn MH (2004) Testing for faecal calprotectin (PhiCal) in the Norwegian Colorectal Cancer Prevention trial on flexible sigmoidoscopy screening: comparison with an immunochemical test for occult blood (FlexSure OBT). Gut 53:1329-1331
21. Kang JY, Dhar A, Pollok R, Leicester RJ, Benson MJ, Kumar D, Melville D, Neild PJ, Tibbs CJ, Maxwell JD (2004) Diverticular disease of the colon: ethnic differences in frequency. Aliment Pharmacol Ther 19:765-769
22. Souques M, Lassalle M, Guldner L, Asselain B, Barres D, Pavis C, Dubois G, Martin E, Flejou JF (2006) Colorectal polyps and cancers diagnosed by pathologists in Ile de France Region Crisapif-Petri Study. Gastroenterol Clin Biol 30:587-593
23. Dobbins C, Defontgalland D, Duthie G, Wattchow DA (2006) The relationship of obesity to the complications of diverticular disease. Colorectal Dis 8:37-40
24. Betes M, Munoz-Navas MA, Duque JM, Angos R, Macias E, Subtil JC, Herraiz M, De La Riva S, Delgado-Rodriguez M, Martinez-Gonzalez MA (2003) Use of colonoscopy as a primary screening test for colorectal cancer in average risk people. Am J Gastroenterol 98:2648-2654